Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Metabasis Therapeutics initiates phase Ib trial of MB-07811 for hyperlipidemia

June 27, 2007

ICAgen and McNeil terminate senicapoc collaboration

June 27, 2007

Supprelin LA launched for central precocious puberty

June 26, 2007

European CHMP recommends approval of Sandoz's biosimilar epoetin alfa

June 26, 2007

Endometrin approved for use in assisted reproductive technology treatment

June 26, 2007

Recent GTx patent reports novel therapeutic agents for osteoporosis

June 26, 2007

FDA approves sugar-free Carnitor for carnitine deficiency

June 25, 2007

E.U. approval for Soliris

June 25, 2007

End of phase II meeting for Qnexa

June 25, 2007

Successful follow-up study of QR-443 in cachexia model

June 25, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...